Coding Corner Question

A 61-year-old established patient with severe RA comes in for a scheduled methotrexate injection and infliximab infusion; 600 mg of infliximab is set aside and mixed. The patient is injected with 15 mg of methotrexate. The patient also has a detailed problem history, a detailed examination, and a medical decision-making of moderate complexity due to a complaint of fatigue and joint pain. Thirty-five minutes into the infusion, the patient has a reaction to the infliximab. The infusion is discontinued after 200 mg of infliximab is infused, and an intravenous injection of methylprednisolone sodium succinate, 40 mg, is given. IV hydration of saline is continued for forty minutes to flush out the infliximab. All documentation is noted appropriately. How do you code for correct reimbursement?

Click here for the answer.

Over the past few years, biosimilars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options, others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and small molecule inhibitor drugs…

Handpicked Reviews of Contemporary Literature

Over the past few years, biosimilars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options; others have few or only off-label options. This series, Rheumatology Drugs at a Glance, provides streamlined information on the administration of biologic, biosimilar and other medications used to…

Over the past few years, biosimilars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug option; others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and other medications used to…

Rheumatology Drugs at a Glance, Part 3: Rheumatoid Arthritis

Reading Rheum

Clinical Insights into Axial Spondyloarthritis: Rheumatology Drugs at a Glance, Part 5

Rheumatology Drugs at a Glance, Part 2: Psoriasis

Related Articles